SlideShare une entreprise Scribd logo
1  sur  6
Télécharger pour lire hors ligne
RETAIL RESEARCH Page | 1
HDFC sec Scrip code Industry CMP (Rs.) Recommended Action Entry price band (Rs.)* Target (Rs.) Time Horizon
TCSLTDEQNR IT 2586.9 Buy on dips 2300‐2364 2620 1 quarter
*Applicable till the next results are announced
In our results review dated April 22, 2014, we recommended existing investors to hold TCS and advised fresh buying on dips to 2002‐2057 for a price target of Rs. 2327.
Thereafter the stock touched a low of Rs. 2000.5 on May 19, 2014 and subsequently met our price target on June 26, 2014. The stock touched a new high of Rs. 2595 on
July 23, 2014. Currently it is quoting at Rs. 2586.9.
TCS recently reported its Q1FY15 results, which were in line on revenue front & at operating level. However, the net profits were above our estimates, aided by higher
other income. We present an update on the stock.
Key highlights of Q1FY15 results: (IFRS)
Consolidated net revenues for the quarter increased by 22.9% Y‐o‐Y and by 2.6% Q‐o‐Q to Rs. 221.1 bn. USD revenues increased by 5.5% Q‐o‐Q, led by a robust 5.7%
growth in volumes. EBITDA margins improved by 15 bps Y‐o‐Y, but fell by 208 bps Q‐o‐Q to 28.8%. EBIT margins declined by 74 bps Y‐o‐Y & by 285 bps Q‐o‐Q to 26.3%.
Sequential fall in EBIT margins was due to wage hikes (‐219 bps), rupee appreciation (‐73 bps) & higher depreciation (‐80 bps) due to one‐time depreciation charge.
However, higher utilisation & operational efficiencies (positive impact of 87 bps Q‐o‐Q) protected further downside in margins.
However, higher other income (up 84.3% Y‐o‐Y & 16.6% Q‐o‐Q), decline in the effective tax rate (down 11 bps Y‐o‐Y & 28 bps Q‐o‐Q to 23.1%) and decline in minority
interest (down 52.9% Y‐o‐Y & 21.2% Q‐o‐Q) boosted the PAT growth, up 26.9% Y‐o‐Y & down 4.5% Q‐o‐Q (though better than expected).
EPS for the quarter stood at Rs. 25.8 vs. Rs. 20.4 in Q1FY14 & Rs. 27 in Q4FY14.
Quarter Financials: (IFRS)
Particulars (Rs. in Million) Q1FY15 Q1FY14 VAR [%] Q4FY14 VAR [%] Remarks
Revenues 221110 179871 22.9 215511 2.6
• USD revenues increased by 5.5% Q‐o‐Q, led by a robust 5.7% growth in volumes. While the
blended realisations fell by 1%, onsite shift aided the Q‐o‐Q revenue growth by 0.8%. In
Constant currency terms revenues grew by 4.8% Q‐o‐Q.
• Geographically, the growth was broad based driven by North America, UK, India & Asia
Pacific. Amongst the verticals, Media & Entertainment, Life Sciences & Healthcare, Hi‐tech
and Travel & Hospitality were the major growth drivers.
Cost of Revenues 118824 94891 25.2 112171 5.9
Gross Profit 102286 84980 20.4 103340 ‐1.0
SGA Expenses 38616 33448 15.5 36806 4.9 SG&A / Net Sales fell by 113 bps Y‐o‐Y, but rose 39 bps Q‐o‐Q to 17.5%.
EBIDTA 63670 51532 23.6 66534 ‐4.3
Depreciation & Amortisation 5521 2905 90.1 3724 48.3 Sharp Y‐o‐Y & Q‐o‐Q rise in depreciation cost was due to one‐time depreciation charge of Rs.
RETAIL RESEARCH July 23, 2014Tata Consultancy Services Ltd. (TCS) – Q1FY15 Result Update
RETAIL RESEARCH Page | 2
1730 mn incurred on assets with ‘NIL’ useful life.
EBIT 58149 48627 19.6 62810 ‐7.4
Other Income, net 8151 4422 84.3 6990 16.6
Other income included forex gains of Rs. 3200 mn in Q1FY15 compared to Rs. 2044.8 mn gains in
Q4FY14.
PBT 66300 53049 25.0 69800 ‐5.0
Provision for Tax 15312 12312 24.4 16313 ‐6.1 Effective tax rate on PBT fell by 11 bps Y‐o‐Y & 28 bps Q‐o‐Q to 23.1%.
PAT 50988 40737 25.2 53487 ‐4.7
Minority Interest 410 870 ‐52.9 520 ‐21.2
Adjusted PAT 50578 39867 26.9 52967 ‐4.5
Net profits were higher than our estimates, boosted by higher other income, decline in the
effective tax rate and decline in minority interest.
Equity 1957.2 1957.2 0.0 1958.7 ‐0.1
EPS 25.8 20.4 26.9 27.0 ‐4.4
FV 1 1 0.0 1 0.0
Cost of Rev. / Net Sales (%) 53.7 52.8 52.0
Gross Profit / Net Sales (%) 46.3 47.2 48.0
SGA Expenses / Net Sales 17.5 18.6 17.1
Tax Rate (%) 23.1 23.2 23.4
EBITDAM (%) 28.80 28.7 30.9
EBITM (%) 26.3 27.0 29.1
Sequential fall in EBIT margins was due to wage hikes (‐219 bps), rupee appreciation (‐73 bps) &
higher depreciation (‐80 bps) due to one‐time depreciation charge. However, higher utilisation &
operational efficiencies (positive impact of 87 bps Q‐o‐Q) protected further downside in margins.
PATM (%) 22.9 22.2 24.6
(Source: Company, HDFC Sec)
Some observations on Q1FY15 results:
• Geographically, the revenue growth (in INR terms) was broad based with North America, UK, India & Asia Pacific being the major growth contributors, up 2.6%, 2.3%,
5.2% & 4.5% Q‐o‐Q respectively. Continental Europe & Latin America grew by 1.8% & 1.4% Q‐o‐Q respectively. However, MEA disappointed, reporting de‐growth of
2% Q‐o‐Q. In June 2014 quarter, TCS posted the highest incremental revenue of $191 mn in the last 15 quarters driven by holistic growth across markets led by North
America.
Geography wise revenue distribution:
Particulars Q1FY14 Q4FY14 Q1FY14
North America 52.2% 52.2% 54.1%
Latin America 2.2% 2.2% 2.4%
UK 17.7% 17.8% 17.0%
Continental Europe 12.0% 12.1% 9.9%
RETAIL RESEARCH Page | 3
India 6.3% 6.2% 7.6%
Asia Pacific 7.6% 7.4% 6.9%
MEA 2.0% 2.1% 2.1%
• Addition of clients during the quarter remained healthy and across the board. The Clients in $50 mn+ band increased by 5 Q‐o‐Q, while no of $20 mn+ and $10 mn+
clients increased by 8 & 13 Q‐o‐Q respectively in Q1FY15. The company closed 7 large deal wins during the quarter.
• Employee Metrics
Q1FY15 Q4FY14 Q1FY14 Remarks
Total No of Employees incl. Indian
Subsidiaries
305431 300464 277586
Gross Addition # 15817 18564 10611
Of the total Gross Additions, 3452 were trainees & 8488 were Lateral additions. Overseas employees were
3877. The company has maintained its hiring target of ~55000 in FY15. It extended offers to 25,000 campus
graduates and ~3,000 of them joined in Q1FY15.
Net Addition # 4967 9751 1390
Attrition Rate (IT services) 12.0% 10.4% 10.5% Attrition rate increased by 160 bps Q‐o‐Q & by 150 bps Y‐o‐Y. Still it continues to remain best in industry.
Utilisation Rate:
Including Trainees 79.8% 77.9% 72.5%
Excluding Trainees 85.3% 83.8% 82.7%
Utilization rate improved on both Y‐o‐Y & Q‐o‐Q basis, which was encouraging and at a multi quarter high.
The management stated that it would continue to operate at higher utilization rates considering its large
headcount base.
# Excl. Indian subsidiaries
• The revenue growth (INR) during the quarter was largely driven by Media & Entertainment, Life Sciences & Healthcare, Hi‐tech and Travel & Hospitality which grew by
9.8%, 6.4%, 5.6% & 5.6% Q‐o‐Q respectively. Energy & Utilities, Retail & Distribution and Telecom verticals also grew at a robust pace by 5%, 4.3% & 4% respectively.
However, Manufacturing grew marginally by 2.6%, while revenues from the dominant BFSI business de‐grew by 0.3% Q‐o‐Q. The insurance portion of financial
segments was one weak area as a result of which the segment revenues declined sequentially. However, management expects this segment to start growing again
from September 2014 quarter although FY15 growth would likely lag overall company growth.
Revenue by Industry Vertical (%)
Verticals Q1FY15 Q4FY14 Q1FY14
BFSI 41.7% 42.9% 43.0%
Telecom 9.4% 9.3% 9.6%
Retail & Distribution 13.8% 13.5% 14.0%
Manufacturing 8.6% 8.6% 8.4%
Hi‐Tech 5.5% 5.3% 5.5%
RETAIL RESEARCH Page | 4
Life Sciences & Healthcare 6.3% 6.1% 5.5%
Travel & Hospitality 3.6% 3.5% 3.4%
Energy & Utilities 3.9% 3.8% 3.7%
Media & Entertainment 2.7% 2.6% 2.1%
Others 4.5% 4.4% 4.8%
• All the service lines the growth was driven by Infrastructure Services (up 7.2% Q‐o‐Q), Assurance (up 5.9% Q‐o‐Q) & Enterprise Solutions (up 4.1% Q‐o‐Q). ADM also
grew at decent pace of 2% Q‐o‐Q. However, Asset Leverage Solutions, Engineering & Industrial Services and Global consulting disappointed with de‐growth of 3.5%,
2.6% & 2.1% Q‐o‐Q respectively. BPO services grew marginally by 0.3% Q‐o‐Q.
• Revenue by Service Offerings (%)
Service Offerings Q1FY15 Q4FY14 Q1FY13
IT Solutions & Services
Application Development & Maintenance 40.8% 41.0% 42.3%
Enterprise Solutions 15.9% 15.7% 15.1%
Assurance Services 8.6% 8.4% 8.1%
Engineering & Industrial Services 4.5% 4.8% 4.7%
Infrastructure Services 12.6% 12.0% 11.9%
Global Consulting 3.2% 3.4% 3.5%
Asset Leverage Solutions 2.5% 2.6% 2.5%
Business Process Outsourcing 11.9% 12.1% 11.9%
Other highlights
• TCS signed 7 large deals during the quarter, 2 in Retail and one each in Hi‐tech, BFS, Insurance and Life Sciences. It is currently in active discussion in at least 8 large
deals, spread across industries.
• In the digital space, the company has won many orders. For instance, it won an engagement with an American healthcare and insurance company to build big data
platform for enabling 360 degree customer view. Further, the company was selected by a large North American food retail chain to develop digital applications that
provide 'on the go' analytics and enable quicker decision making for store managers. The company was also chosen by a leading global insurance major to develop
customer centric sales applications using digital technologies
• As of June 30, 2014, the company has applied for 1804 patents including 58 applied during the quarter. Till date, the company has been granted 129 patents.
• On the occasion of the 10th anniversary of TCS' IPO TCS announced a special dividend of Rs. 40 per share in addition to interim dividend of Rs. 5 per share. The special
dividend by itself would entail a payout of over Rs. 80 bn for the company or about a third of its current cash balance.
RETAIL RESEARCH Page | 5
Conclusion & Recommendation
TCS’s Q1FY15 sequential revenue & operating profit growth was in line, while PAT growth was ahead of our estimates, aided by higher other income. Healthy volume
growth, lower than expected decline in EBIT margins (supported by improvement in utilisation & operational efficiencies), healthy growth across industries and key
markets & optimistic management commentary on IT industry outlook were positive highlights of the quarter. Strong growth witnessed in North America & UK, its key
markets was encouraging.
The company stated that it has a strong demand pipeline in place and its customer‐centric mindset, leadership in the Digital space and strong execution capabilities will
help it sustain momentum. Under‐penetration led growth in Europe and discretionary/digital spending led growth from US would fuel revenue growth. The management
continues to reiterate that the usual phenomenon of H1 being stronger than H2 would hold true in FY15. Among verticals, TCS indicates that apart from good prospects in
Manufacturing, Retail, Hi Tech and Life sciences, it should see very strong growth in BFSI and Telecom in FY15 (company believes both the verticals could go ahead of
company level average). The management is very bullish on Digital business going forward. As per the management, the growth prospects remain rock solid in Europe
both for the sector and for the company as the market continues to become more amenable for offshoring/outsourcing with TCS's early investments in the market
expected to continue driving results.
The company's disciplined stance in operations has helped it mitigate the impact of multiple headwinds like currency movements, accelerated depreciation norms and
wage hikes during the quarter. Looking ahead, the company plans to continue to maintain its EBIT margins in its desired band of 26‐28% by operating efficiently.
While we expect revenue growth of TCS to remain healthy over the next one to two years, wage hikes and continued re‐investment in the business could put pressure on
the margins. While the management has stated that it would continue to operate at higher utilization rates considering its large headcount base, we feel utilisation is
near to peak levels and hence offers limited scope for improvement. We expect the margins in FY15 to be lower than that reported in FY14. However, the operational
efficiencies would limit the downside.
We feel TCS is on track to achieve our FY15 revenue & operating profit projections. Hence we are keeping the same unchanged. However, we feel the company could
surpass our PAT estimates. Hence we are enhancing the same by 3.1%. Accordingly revised EPS for FY15 is estimated at Rs. 111.6 (vs Rs. 108.2 originally estimated). We
have incorporated FY16 projections, wherein we expect TCS’s net sales, operating profit & PAT to grow by 16%, 14.1% & 14.5% respectively. EPS is projected at Rs. 127.8.
At CMP, the stock trades at 20.2x FY16E EPS, which is at a premium to its nearest peers Infosys & Wipro. We expect premium valuations of TCS to sustain, considering its
past superior execution track record, better visibility in terms of resource planning given its lowest attrition level in the industry.
Valuing the stock at 20.5xFY16E EPS, we arrive at a price target of Rs. 2620. The stock offers limited upside from current levels. Hence, for better returns and margin of
safety, we advise investors to buy it only on dips to Rs. 2300‐2364 (18‐18.5xFY15E EPS) for our price target over the next quarter.
RETAIL RESEARCH Page | 6
Financial Estimates: (IFRS)
Particulars (Rs. in Millions) FY12 FY13 FY14 FY15 (OE)* FY15 (RE)* FY16 (E)
Net Revenue 488938 629895 818094 942287 942287 1093053
EBIDTA 144176 180872 251323 281744 281744 321358
Adjusted PAT 106382 139060 191168 212015 218611 250309
EPS (Rs.) 54.4 71.1 97.6 108.2 111.6 127.8
OPM (%) 29.5 28.7 30.7 29.9 29.9 29.4
PATM (%) 21.8 22.1 23.4 22.5 23.2 22.9
PE 47.6 36.4 26.5 23.9 23.2 20.2
*OE = Original Estimates; RE = Revised Estimates (Source: Company, HDFC Sec Estimates)
Analyst: Mehernosh K. Panthaki – IT, FMCG & Midcaps; Email ID: mehernosh.panthaki@hdfcsec.com
RETAIL RESEARCH Tel: (022) 3075 3400 Fax: (022) 2496 5066 Corporate Office
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022)
2496 5066 Website: www.hdfcsec.com Email: hdfcsecretailresearch@hdfcsec.com
Disclaimer: This document has been prepared by HDFC Securities Limited and is meant for sole use by the recipient and not for circulation. This document is not to be reported or copied or made available to
others. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. The information contained herein is from sources believed reliable. We do not represent that it is accurate or
complete and it should not be relied upon as such. We may have from time to time positions or options on, and buy and sell securities referred to herein. We may from time to time solicit from, or perform investment
banking, or other services for, any company mentioned in this document. This report is intended for non-Institutional Clients

Contenu connexe

Tendances

Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...corporationlkq
 
Garmin 2016 Q1 earning s call webcast slides
Garmin 2016 Q1 earning s call webcast slidesGarmin 2016 Q1 earning s call webcast slides
Garmin 2016 Q1 earning s call webcast slidesLudovic Privat
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangIndiaNotes.com
 
Q3 2016 earnings deck final
Q3 2016 earnings deck finalQ3 2016 earnings deck final
Q3 2016 earnings deck finalgreif2015
 
Thulin bernstein conference final
Thulin bernstein conference finalThulin bernstein conference final
Thulin bernstein conference finalInvestors_3M
 
Garmin Q3 2015 earnings call presneentation
Garmin Q3 2015 earnings call presneentationGarmin Q3 2015 earnings call presneentation
Garmin Q3 2015 earnings call presneentationLudovic Privat
 
Q1 2015 earnings slides final
Q1 2015 earnings slides finalQ1 2015 earnings slides final
Q1 2015 earnings slides finalInvestorBruker
 
2 q14 slides final
2 q14 slides final2 q14 slides final
2 q14 slides finalDupontInv
 
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecJyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecIndiaNotes.com
 
Td securities-forest-products-forum
Td securities-forest-products-forumTd securities-forest-products-forum
Td securities-forest-products-forumgreif2015
 
Fiscal Year Ended March 2018 (FY2017) Financial Results Briefing
Fiscal Year Ended March 2018 (FY2017) Financial Results BriefingFiscal Year Ended March 2018 (FY2017) Financial Results Briefing
Fiscal Year Ended March 2018 (FY2017) Financial Results BriefingRicohLease
 
Q1 2017 Earnings Presentation
Q1 2017 Earnings PresentationQ1 2017 Earnings Presentation
Q1 2017 Earnings Presentationingersollrand2016
 
Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18InvestorBruker
 
Lkq third-quarter-2016-earnings-call-presentation
Lkq third-quarter-2016-earnings-call-presentationLkq third-quarter-2016-earnings-call-presentation
Lkq third-quarter-2016-earnings-call-presentationcorporationlkq
 
TE Connectivity Q2 2017 Earnings Presentation
TE Connectivity Q2 2017 Earnings PresentationTE Connectivity Q2 2017 Earnings Presentation
TE Connectivity Q2 2017 Earnings PresentationTEConnectivityltd
 
Lkq jp-morgan-auto-conference-2018-investor-presentation
Lkq jp-morgan-auto-conference-2018-investor-presentationLkq jp-morgan-auto-conference-2018-investor-presentation
Lkq jp-morgan-auto-conference-2018-investor-presentationcorporationlkq
 
intel First Quarter 2006 Earnings Release
intel  First Quarter 2006 Earnings Releaseintel  First Quarter 2006 Earnings Release
intel First Quarter 2006 Earnings Releasefinance6
 
Lkq q2-2018-earnings-call-presentation finalfinal
Lkq q2-2018-earnings-call-presentation finalfinalLkq q2-2018-earnings-call-presentation finalfinal
Lkq q2-2018-earnings-call-presentation finalfinalcorporationlkq
 
LKQ Corporation's 2018 Investor Day Presentation
LKQ Corporation's 2018 Investor Day PresentationLKQ Corporation's 2018 Investor Day Presentation
LKQ Corporation's 2018 Investor Day Presentationcorporationlkq
 

Tendances (20)

Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
 
Garmin 2016 Q1 earning s call webcast slides
Garmin 2016 Q1 earning s call webcast slidesGarmin 2016 Q1 earning s call webcast slides
Garmin 2016 Q1 earning s call webcast slides
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
 
Q3 2016 earnings deck final
Q3 2016 earnings deck finalQ3 2016 earnings deck final
Q3 2016 earnings deck final
 
Thulin bernstein conference final
Thulin bernstein conference finalThulin bernstein conference final
Thulin bernstein conference final
 
Garmin Q3 2015 earnings call presneentation
Garmin Q3 2015 earnings call presneentationGarmin Q3 2015 earnings call presneentation
Garmin Q3 2015 earnings call presneentation
 
Q1 2015 earnings slides final
Q1 2015 earnings slides finalQ1 2015 earnings slides final
Q1 2015 earnings slides final
 
First Quarter 2016 Results
First Quarter 2016 ResultsFirst Quarter 2016 Results
First Quarter 2016 Results
 
2 q14 slides final
2 q14 slides final2 q14 slides final
2 q14 slides final
 
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecJyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
 
Td securities-forest-products-forum
Td securities-forest-products-forumTd securities-forest-products-forum
Td securities-forest-products-forum
 
Fiscal Year Ended March 2018 (FY2017) Financial Results Briefing
Fiscal Year Ended March 2018 (FY2017) Financial Results BriefingFiscal Year Ended March 2018 (FY2017) Financial Results Briefing
Fiscal Year Ended March 2018 (FY2017) Financial Results Briefing
 
Q1 2017 Earnings Presentation
Q1 2017 Earnings PresentationQ1 2017 Earnings Presentation
Q1 2017 Earnings Presentation
 
Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18
 
Lkq third-quarter-2016-earnings-call-presentation
Lkq third-quarter-2016-earnings-call-presentationLkq third-quarter-2016-earnings-call-presentation
Lkq third-quarter-2016-earnings-call-presentation
 
TE Connectivity Q2 2017 Earnings Presentation
TE Connectivity Q2 2017 Earnings PresentationTE Connectivity Q2 2017 Earnings Presentation
TE Connectivity Q2 2017 Earnings Presentation
 
Lkq jp-morgan-auto-conference-2018-investor-presentation
Lkq jp-morgan-auto-conference-2018-investor-presentationLkq jp-morgan-auto-conference-2018-investor-presentation
Lkq jp-morgan-auto-conference-2018-investor-presentation
 
intel First Quarter 2006 Earnings Release
intel  First Quarter 2006 Earnings Releaseintel  First Quarter 2006 Earnings Release
intel First Quarter 2006 Earnings Release
 
Lkq q2-2018-earnings-call-presentation finalfinal
Lkq q2-2018-earnings-call-presentation finalfinalLkq q2-2018-earnings-call-presentation finalfinal
Lkq q2-2018-earnings-call-presentation finalfinal
 
LKQ Corporation's 2018 Investor Day Presentation
LKQ Corporation's 2018 Investor Day PresentationLKQ Corporation's 2018 Investor Day Presentation
LKQ Corporation's 2018 Investor Day Presentation
 

Similaire à TCS Q1FY15: Results in-line, buy on dips

MindTree: Rupee appreciation drags revenue growth during Q1FY15
MindTree: Rupee appreciation drags revenue growth during Q1FY15MindTree: Rupee appreciation drags revenue growth during Q1FY15
MindTree: Rupee appreciation drags revenue growth during Q1FY15IndiaNotes.com
 
Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014IndiaNotes.com
 
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 LIC Housing Finance Q1FY15: Buy for a target of Rs332 LIC Housing Finance Q1FY15: Buy for a target of Rs332
LIC Housing Finance Q1FY15: Buy for a target of Rs332IndiaNotes.com
 
Ofx 260515 fy15_presentation
Ofx 260515 fy15_presentationOfx 260515 fy15_presentation
Ofx 260515 fy15_presentationabsmartkarma
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationJigar Savla
 
Dabur India Q1FY15: Maintain neutral
 Dabur India Q1FY15: Maintain neutral Dabur India Q1FY15: Maintain neutral
Dabur India Q1FY15: Maintain neutralIndiaNotes.com
 
Q4 15 earnings slides final
Q4 15 earnings slides finalQ4 15 earnings slides final
Q4 15 earnings slides finalInvestorBruker
 
Q2 2014 Earnings Slides
Q2 2014 Earnings SlidesQ2 2014 Earnings Slides
Q2 2014 Earnings SlidesInvestorBruker
 
HCL Q1FY15: Revenue below estimate on lower IMS growth; buy
 HCL Q1FY15: Revenue below estimate on lower IMS growth; buy HCL Q1FY15: Revenue below estimate on lower IMS growth; buy
HCL Q1FY15: Revenue below estimate on lower IMS growth; buyIndiaNotes.com
 
KPDL_Result Presentation_Q4 and FY15
KPDL_Result Presentation_Q4 and FY15KPDL_Result Presentation_Q4 and FY15
KPDL_Result Presentation_Q4 and FY15Varun Parwal
 
Bajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdBajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdIndiaNotes.com
 
Q4 2014 earnings slides final
Q4 2014 earnings slides finalQ4 2014 earnings slides final
Q4 2014 earnings slides finalInvestorBruker
 
Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Angel Broking
 
Q3 2014 earnings slides final
Q3 2014 earnings slides finalQ3 2014 earnings slides final
Q3 2014 earnings slides finalInvestorBruker
 
FLFLInvestor_PPT_Q3FY19.pdf
FLFLInvestor_PPT_Q3FY19.pdfFLFLInvestor_PPT_Q3FY19.pdf
FLFLInvestor_PPT_Q3FY19.pdfSanketPingale12
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic PharmaIndiaNotes.com
 

Similaire à TCS Q1FY15: Results in-line, buy on dips (20)

MindTree: Rupee appreciation drags revenue growth during Q1FY15
MindTree: Rupee appreciation drags revenue growth during Q1FY15MindTree: Rupee appreciation drags revenue growth during Q1FY15
MindTree: Rupee appreciation drags revenue growth during Q1FY15
 
TCS Fact Sheet Q1 FY15
TCS Fact Sheet Q1 FY15TCS Fact Sheet Q1 FY15
TCS Fact Sheet Q1 FY15
 
Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014Hdfc securities wipro_29_oct_2014
Hdfc securities wipro_29_oct_2014
 
TCS Fact Sheet Q4 FY14
TCS Fact Sheet Q4 FY14TCS Fact Sheet Q4 FY14
TCS Fact Sheet Q4 FY14
 
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 LIC Housing Finance Q1FY15: Buy for a target of Rs332 LIC Housing Finance Q1FY15: Buy for a target of Rs332
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 
Ofx 260515 fy15_presentation
Ofx 260515 fy15_presentationOfx 260515 fy15_presentation
Ofx 260515 fy15_presentation
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 Presentation
 
Dabur India Q1FY15: Maintain neutral
 Dabur India Q1FY15: Maintain neutral Dabur India Q1FY15: Maintain neutral
Dabur India Q1FY15: Maintain neutral
 
Q4 15 earnings slides final
Q4 15 earnings slides finalQ4 15 earnings slides final
Q4 15 earnings slides final
 
Q2 2014 Earnings Slides
Q2 2014 Earnings SlidesQ2 2014 Earnings Slides
Q2 2014 Earnings Slides
 
HCL Q1FY15: Revenue below estimate on lower IMS growth; buy
 HCL Q1FY15: Revenue below estimate on lower IMS growth; buy HCL Q1FY15: Revenue below estimate on lower IMS growth; buy
HCL Q1FY15: Revenue below estimate on lower IMS growth; buy
 
KPDL_Result Presentation_Q4 and FY15
KPDL_Result Presentation_Q4 and FY15KPDL_Result Presentation_Q4 and FY15
KPDL_Result Presentation_Q4 and FY15
 
Final
FinalFinal
Final
 
Bajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdBajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; hold
 
Q4 2014 earnings slides final
Q4 2014 earnings slides finalQ4 2014 earnings slides final
Q4 2014 earnings slides final
 
Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010
 
Q3 2014 earnings slides final
Q3 2014 earnings slides finalQ3 2014 earnings slides final
Q3 2014 earnings slides final
 
FLFLInvestor_PPT_Q3FY19.pdf
FLFLInvestor_PPT_Q3FY19.pdfFLFLInvestor_PPT_Q3FY19.pdf
FLFLInvestor_PPT_Q3FY19.pdf
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 

Plus de IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 

Plus de IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Dernier

Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbaiVasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbaipriyasharma62062
 
Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...
Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...
Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...priyasharma62062
 
Pension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfPension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfHenry Tapper
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...dipikadinghjn ( Why You Choose Us? ) Escorts
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesFalcon Invoice Discounting
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumFinTech Belgium
 
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...dipikadinghjn ( Why You Choose Us? ) Escorts
 
➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men 🔝Malda🔝 Escorts Ser...
➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men  🔝Malda🔝   Escorts Ser...➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men  🔝Malda🔝   Escorts Ser...
➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men 🔝Malda🔝 Escorts Ser...amitlee9823
 
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...priyasharma62062
 
Strategic Resources May 2024 Corporate Presentation
Strategic Resources May 2024 Corporate PresentationStrategic Resources May 2024 Corporate Presentation
Strategic Resources May 2024 Corporate PresentationAdnet Communications
 
call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️
call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️
call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...
Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...
Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...priyasharma62062
 
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...priyasharma62062
 
VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...dipikadinghjn ( Why You Choose Us? ) Escorts
 
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...Henry Tapper
 
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...priyasharma62062
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfMichael Silva
 
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...amitlee9823
 
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...dipikadinghjn ( Why You Choose Us? ) Escorts
 

Dernier (20)

Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbaiVasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
 
Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...
Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...
Diva-Thane European Call Girls Number-9833754194-Diva Busty Professional Call...
 
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
 
Pension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfPension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdf
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunities
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech Belgium
 
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
 
➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men 🔝Malda🔝 Escorts Ser...
➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men  🔝Malda🔝   Escorts Ser...➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men  🔝Malda🔝   Escorts Ser...
➥🔝 7737669865 🔝▻ Malda Call-girls in Women Seeking Men 🔝Malda🔝 Escorts Ser...
 
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
 
Strategic Resources May 2024 Corporate Presentation
Strategic Resources May 2024 Corporate PresentationStrategic Resources May 2024 Corporate Presentation
Strategic Resources May 2024 Corporate Presentation
 
call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️
call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️
call girls in Sant Nagar (DELHI) 🔝 >༒9953056974 🔝 genuine Escort Service 🔝✔️✔️
 
Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...
Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...
Mira Road Awesome 100% Independent Call Girls NUmber-9833754194-Dahisar Inter...
 
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
 
VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Taloja 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
 
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
 
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdf
 
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
 
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
 

TCS Q1FY15: Results in-line, buy on dips

  • 1. RETAIL RESEARCH Page | 1 HDFC sec Scrip code Industry CMP (Rs.) Recommended Action Entry price band (Rs.)* Target (Rs.) Time Horizon TCSLTDEQNR IT 2586.9 Buy on dips 2300‐2364 2620 1 quarter *Applicable till the next results are announced In our results review dated April 22, 2014, we recommended existing investors to hold TCS and advised fresh buying on dips to 2002‐2057 for a price target of Rs. 2327. Thereafter the stock touched a low of Rs. 2000.5 on May 19, 2014 and subsequently met our price target on June 26, 2014. The stock touched a new high of Rs. 2595 on July 23, 2014. Currently it is quoting at Rs. 2586.9. TCS recently reported its Q1FY15 results, which were in line on revenue front & at operating level. However, the net profits were above our estimates, aided by higher other income. We present an update on the stock. Key highlights of Q1FY15 results: (IFRS) Consolidated net revenues for the quarter increased by 22.9% Y‐o‐Y and by 2.6% Q‐o‐Q to Rs. 221.1 bn. USD revenues increased by 5.5% Q‐o‐Q, led by a robust 5.7% growth in volumes. EBITDA margins improved by 15 bps Y‐o‐Y, but fell by 208 bps Q‐o‐Q to 28.8%. EBIT margins declined by 74 bps Y‐o‐Y & by 285 bps Q‐o‐Q to 26.3%. Sequential fall in EBIT margins was due to wage hikes (‐219 bps), rupee appreciation (‐73 bps) & higher depreciation (‐80 bps) due to one‐time depreciation charge. However, higher utilisation & operational efficiencies (positive impact of 87 bps Q‐o‐Q) protected further downside in margins. However, higher other income (up 84.3% Y‐o‐Y & 16.6% Q‐o‐Q), decline in the effective tax rate (down 11 bps Y‐o‐Y & 28 bps Q‐o‐Q to 23.1%) and decline in minority interest (down 52.9% Y‐o‐Y & 21.2% Q‐o‐Q) boosted the PAT growth, up 26.9% Y‐o‐Y & down 4.5% Q‐o‐Q (though better than expected). EPS for the quarter stood at Rs. 25.8 vs. Rs. 20.4 in Q1FY14 & Rs. 27 in Q4FY14. Quarter Financials: (IFRS) Particulars (Rs. in Million) Q1FY15 Q1FY14 VAR [%] Q4FY14 VAR [%] Remarks Revenues 221110 179871 22.9 215511 2.6 • USD revenues increased by 5.5% Q‐o‐Q, led by a robust 5.7% growth in volumes. While the blended realisations fell by 1%, onsite shift aided the Q‐o‐Q revenue growth by 0.8%. In Constant currency terms revenues grew by 4.8% Q‐o‐Q. • Geographically, the growth was broad based driven by North America, UK, India & Asia Pacific. Amongst the verticals, Media & Entertainment, Life Sciences & Healthcare, Hi‐tech and Travel & Hospitality were the major growth drivers. Cost of Revenues 118824 94891 25.2 112171 5.9 Gross Profit 102286 84980 20.4 103340 ‐1.0 SGA Expenses 38616 33448 15.5 36806 4.9 SG&A / Net Sales fell by 113 bps Y‐o‐Y, but rose 39 bps Q‐o‐Q to 17.5%. EBIDTA 63670 51532 23.6 66534 ‐4.3 Depreciation & Amortisation 5521 2905 90.1 3724 48.3 Sharp Y‐o‐Y & Q‐o‐Q rise in depreciation cost was due to one‐time depreciation charge of Rs. RETAIL RESEARCH July 23, 2014Tata Consultancy Services Ltd. (TCS) – Q1FY15 Result Update
  • 2. RETAIL RESEARCH Page | 2 1730 mn incurred on assets with ‘NIL’ useful life. EBIT 58149 48627 19.6 62810 ‐7.4 Other Income, net 8151 4422 84.3 6990 16.6 Other income included forex gains of Rs. 3200 mn in Q1FY15 compared to Rs. 2044.8 mn gains in Q4FY14. PBT 66300 53049 25.0 69800 ‐5.0 Provision for Tax 15312 12312 24.4 16313 ‐6.1 Effective tax rate on PBT fell by 11 bps Y‐o‐Y & 28 bps Q‐o‐Q to 23.1%. PAT 50988 40737 25.2 53487 ‐4.7 Minority Interest 410 870 ‐52.9 520 ‐21.2 Adjusted PAT 50578 39867 26.9 52967 ‐4.5 Net profits were higher than our estimates, boosted by higher other income, decline in the effective tax rate and decline in minority interest. Equity 1957.2 1957.2 0.0 1958.7 ‐0.1 EPS 25.8 20.4 26.9 27.0 ‐4.4 FV 1 1 0.0 1 0.0 Cost of Rev. / Net Sales (%) 53.7 52.8 52.0 Gross Profit / Net Sales (%) 46.3 47.2 48.0 SGA Expenses / Net Sales 17.5 18.6 17.1 Tax Rate (%) 23.1 23.2 23.4 EBITDAM (%) 28.80 28.7 30.9 EBITM (%) 26.3 27.0 29.1 Sequential fall in EBIT margins was due to wage hikes (‐219 bps), rupee appreciation (‐73 bps) & higher depreciation (‐80 bps) due to one‐time depreciation charge. However, higher utilisation & operational efficiencies (positive impact of 87 bps Q‐o‐Q) protected further downside in margins. PATM (%) 22.9 22.2 24.6 (Source: Company, HDFC Sec) Some observations on Q1FY15 results: • Geographically, the revenue growth (in INR terms) was broad based with North America, UK, India & Asia Pacific being the major growth contributors, up 2.6%, 2.3%, 5.2% & 4.5% Q‐o‐Q respectively. Continental Europe & Latin America grew by 1.8% & 1.4% Q‐o‐Q respectively. However, MEA disappointed, reporting de‐growth of 2% Q‐o‐Q. In June 2014 quarter, TCS posted the highest incremental revenue of $191 mn in the last 15 quarters driven by holistic growth across markets led by North America. Geography wise revenue distribution: Particulars Q1FY14 Q4FY14 Q1FY14 North America 52.2% 52.2% 54.1% Latin America 2.2% 2.2% 2.4% UK 17.7% 17.8% 17.0% Continental Europe 12.0% 12.1% 9.9%
  • 3. RETAIL RESEARCH Page | 3 India 6.3% 6.2% 7.6% Asia Pacific 7.6% 7.4% 6.9% MEA 2.0% 2.1% 2.1% • Addition of clients during the quarter remained healthy and across the board. The Clients in $50 mn+ band increased by 5 Q‐o‐Q, while no of $20 mn+ and $10 mn+ clients increased by 8 & 13 Q‐o‐Q respectively in Q1FY15. The company closed 7 large deal wins during the quarter. • Employee Metrics Q1FY15 Q4FY14 Q1FY14 Remarks Total No of Employees incl. Indian Subsidiaries 305431 300464 277586 Gross Addition # 15817 18564 10611 Of the total Gross Additions, 3452 were trainees & 8488 were Lateral additions. Overseas employees were 3877. The company has maintained its hiring target of ~55000 in FY15. It extended offers to 25,000 campus graduates and ~3,000 of them joined in Q1FY15. Net Addition # 4967 9751 1390 Attrition Rate (IT services) 12.0% 10.4% 10.5% Attrition rate increased by 160 bps Q‐o‐Q & by 150 bps Y‐o‐Y. Still it continues to remain best in industry. Utilisation Rate: Including Trainees 79.8% 77.9% 72.5% Excluding Trainees 85.3% 83.8% 82.7% Utilization rate improved on both Y‐o‐Y & Q‐o‐Q basis, which was encouraging and at a multi quarter high. The management stated that it would continue to operate at higher utilization rates considering its large headcount base. # Excl. Indian subsidiaries • The revenue growth (INR) during the quarter was largely driven by Media & Entertainment, Life Sciences & Healthcare, Hi‐tech and Travel & Hospitality which grew by 9.8%, 6.4%, 5.6% & 5.6% Q‐o‐Q respectively. Energy & Utilities, Retail & Distribution and Telecom verticals also grew at a robust pace by 5%, 4.3% & 4% respectively. However, Manufacturing grew marginally by 2.6%, while revenues from the dominant BFSI business de‐grew by 0.3% Q‐o‐Q. The insurance portion of financial segments was one weak area as a result of which the segment revenues declined sequentially. However, management expects this segment to start growing again from September 2014 quarter although FY15 growth would likely lag overall company growth. Revenue by Industry Vertical (%) Verticals Q1FY15 Q4FY14 Q1FY14 BFSI 41.7% 42.9% 43.0% Telecom 9.4% 9.3% 9.6% Retail & Distribution 13.8% 13.5% 14.0% Manufacturing 8.6% 8.6% 8.4% Hi‐Tech 5.5% 5.3% 5.5%
  • 4. RETAIL RESEARCH Page | 4 Life Sciences & Healthcare 6.3% 6.1% 5.5% Travel & Hospitality 3.6% 3.5% 3.4% Energy & Utilities 3.9% 3.8% 3.7% Media & Entertainment 2.7% 2.6% 2.1% Others 4.5% 4.4% 4.8% • All the service lines the growth was driven by Infrastructure Services (up 7.2% Q‐o‐Q), Assurance (up 5.9% Q‐o‐Q) & Enterprise Solutions (up 4.1% Q‐o‐Q). ADM also grew at decent pace of 2% Q‐o‐Q. However, Asset Leverage Solutions, Engineering & Industrial Services and Global consulting disappointed with de‐growth of 3.5%, 2.6% & 2.1% Q‐o‐Q respectively. BPO services grew marginally by 0.3% Q‐o‐Q. • Revenue by Service Offerings (%) Service Offerings Q1FY15 Q4FY14 Q1FY13 IT Solutions & Services Application Development & Maintenance 40.8% 41.0% 42.3% Enterprise Solutions 15.9% 15.7% 15.1% Assurance Services 8.6% 8.4% 8.1% Engineering & Industrial Services 4.5% 4.8% 4.7% Infrastructure Services 12.6% 12.0% 11.9% Global Consulting 3.2% 3.4% 3.5% Asset Leverage Solutions 2.5% 2.6% 2.5% Business Process Outsourcing 11.9% 12.1% 11.9% Other highlights • TCS signed 7 large deals during the quarter, 2 in Retail and one each in Hi‐tech, BFS, Insurance and Life Sciences. It is currently in active discussion in at least 8 large deals, spread across industries. • In the digital space, the company has won many orders. For instance, it won an engagement with an American healthcare and insurance company to build big data platform for enabling 360 degree customer view. Further, the company was selected by a large North American food retail chain to develop digital applications that provide 'on the go' analytics and enable quicker decision making for store managers. The company was also chosen by a leading global insurance major to develop customer centric sales applications using digital technologies • As of June 30, 2014, the company has applied for 1804 patents including 58 applied during the quarter. Till date, the company has been granted 129 patents. • On the occasion of the 10th anniversary of TCS' IPO TCS announced a special dividend of Rs. 40 per share in addition to interim dividend of Rs. 5 per share. The special dividend by itself would entail a payout of over Rs. 80 bn for the company or about a third of its current cash balance.
  • 5. RETAIL RESEARCH Page | 5 Conclusion & Recommendation TCS’s Q1FY15 sequential revenue & operating profit growth was in line, while PAT growth was ahead of our estimates, aided by higher other income. Healthy volume growth, lower than expected decline in EBIT margins (supported by improvement in utilisation & operational efficiencies), healthy growth across industries and key markets & optimistic management commentary on IT industry outlook were positive highlights of the quarter. Strong growth witnessed in North America & UK, its key markets was encouraging. The company stated that it has a strong demand pipeline in place and its customer‐centric mindset, leadership in the Digital space and strong execution capabilities will help it sustain momentum. Under‐penetration led growth in Europe and discretionary/digital spending led growth from US would fuel revenue growth. The management continues to reiterate that the usual phenomenon of H1 being stronger than H2 would hold true in FY15. Among verticals, TCS indicates that apart from good prospects in Manufacturing, Retail, Hi Tech and Life sciences, it should see very strong growth in BFSI and Telecom in FY15 (company believes both the verticals could go ahead of company level average). The management is very bullish on Digital business going forward. As per the management, the growth prospects remain rock solid in Europe both for the sector and for the company as the market continues to become more amenable for offshoring/outsourcing with TCS's early investments in the market expected to continue driving results. The company's disciplined stance in operations has helped it mitigate the impact of multiple headwinds like currency movements, accelerated depreciation norms and wage hikes during the quarter. Looking ahead, the company plans to continue to maintain its EBIT margins in its desired band of 26‐28% by operating efficiently. While we expect revenue growth of TCS to remain healthy over the next one to two years, wage hikes and continued re‐investment in the business could put pressure on the margins. While the management has stated that it would continue to operate at higher utilization rates considering its large headcount base, we feel utilisation is near to peak levels and hence offers limited scope for improvement. We expect the margins in FY15 to be lower than that reported in FY14. However, the operational efficiencies would limit the downside. We feel TCS is on track to achieve our FY15 revenue & operating profit projections. Hence we are keeping the same unchanged. However, we feel the company could surpass our PAT estimates. Hence we are enhancing the same by 3.1%. Accordingly revised EPS for FY15 is estimated at Rs. 111.6 (vs Rs. 108.2 originally estimated). We have incorporated FY16 projections, wherein we expect TCS’s net sales, operating profit & PAT to grow by 16%, 14.1% & 14.5% respectively. EPS is projected at Rs. 127.8. At CMP, the stock trades at 20.2x FY16E EPS, which is at a premium to its nearest peers Infosys & Wipro. We expect premium valuations of TCS to sustain, considering its past superior execution track record, better visibility in terms of resource planning given its lowest attrition level in the industry. Valuing the stock at 20.5xFY16E EPS, we arrive at a price target of Rs. 2620. The stock offers limited upside from current levels. Hence, for better returns and margin of safety, we advise investors to buy it only on dips to Rs. 2300‐2364 (18‐18.5xFY15E EPS) for our price target over the next quarter.
  • 6. RETAIL RESEARCH Page | 6 Financial Estimates: (IFRS) Particulars (Rs. in Millions) FY12 FY13 FY14 FY15 (OE)* FY15 (RE)* FY16 (E) Net Revenue 488938 629895 818094 942287 942287 1093053 EBIDTA 144176 180872 251323 281744 281744 321358 Adjusted PAT 106382 139060 191168 212015 218611 250309 EPS (Rs.) 54.4 71.1 97.6 108.2 111.6 127.8 OPM (%) 29.5 28.7 30.7 29.9 29.9 29.4 PATM (%) 21.8 22.1 23.4 22.5 23.2 22.9 PE 47.6 36.4 26.5 23.9 23.2 20.2 *OE = Original Estimates; RE = Revised Estimates (Source: Company, HDFC Sec Estimates) Analyst: Mehernosh K. Panthaki – IT, FMCG & Midcaps; Email ID: mehernosh.panthaki@hdfcsec.com RETAIL RESEARCH Tel: (022) 3075 3400 Fax: (022) 2496 5066 Corporate Office HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Website: www.hdfcsec.com Email: hdfcsecretailresearch@hdfcsec.com Disclaimer: This document has been prepared by HDFC Securities Limited and is meant for sole use by the recipient and not for circulation. This document is not to be reported or copied or made available to others. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. The information contained herein is from sources believed reliable. We do not represent that it is accurate or complete and it should not be relied upon as such. We may have from time to time positions or options on, and buy and sell securities referred to herein. We may from time to time solicit from, or perform investment banking, or other services for, any company mentioned in this document. This report is intended for non-Institutional Clients